The largest database of trusted experimental protocols

4 protocols using luciferin luciferase

1

Platelet Activation Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
Collagen, thrombin, ADP and luciferin/luciferase were provided by the Chrono-Log Corporation. FITC-phalloidin, H2O2 and mepacrine were purchased from Sigma-Aldrich; Merck KGaA. Antibodies against phospho-ERK1/2 (catalog no. 4370S), phospho-p38 (catalog no. 4511S), phospho-HSP27 (catalog no. 2401S), total-p38 (catalog no. 8690S), total-ERK (catalog no. 4695S) and HSP27 (catalog no. 95357S) were purchased from Cell Signaling Technology Inc. β-actin monoclonal antibody (catalog no. 66009-1-Ig) was obtained from ProteinTech Group, Inc. The antibody for integrin β3 (D-11) (catalog no. sc-365679) was obtained from Santa Cruz Biotechnology Inc. PAC-1 antibodies (catalog no. MA5-28564) were from Invitrogen; Thermo Fisher Scientific, Inc., and CD62P antibodies (catalog no. 555524) were from BD Biosciences.
+ Open protocol
+ Expand
2

Simultaneous Platelet Aggregation and ATP Secretion

Check if the same lab product or an alternative is used in the 5 most similar protocols
Simultaneous monitoring of platelet aggregation and ATP secretion was performed at 37 °C with constant stirring (1000 rpm) in a Chronolog 700 aggregometer (Chronolog, Havertown, PA, USA). For all experiments involving pharmacological inhibitors, platelets (2 × 108 mL− 1) were pre-treated with vehicle control or inhibitors for 10 min. Also, for experiments involving functional blockade of platelet CXCR7, platelets were pre-incubated for 10 min with 10 μg/mL− 1 IV.3 prior to a 10 min incubation with 10 μg/mL− 1 anti-CXCR7 (11G8) or IgG1 control to prevent non-specific platelet activation via the FcγRIIA receptor. Before agonist stimulation, 5 μL of luciferin-luciferase (Chronolog) was added. Post aggregation, 1 nM ATP standard was added as a reference value for quantification of secreted ATP. Data analysis was performed with Aggro/Link5 software (Chronolog).
+ Open protocol
+ Expand
3

Purification and Characterization of HuPK and rBbKI

Check if the same lab product or an alternative is used in the 5 most similar protocols
HuPK was purified as previously described [14 (link)] and the specific activity was found to be 80 U/mg. Recombinant Bauhinia bauhinioides kallikrein inhibitor (rBbKI) was obtained as described [15 (link)]. ADP, ATP-standard, and luciferin-luciferase were from Chrono-Log (Chester, PA, USA). Human α-thrombin (200 NIH units/mg) was from Sigma (St. Louis, MO, USA). The PAR-1 antagonist SCH 79797 was from Cayman Chemical (Ann Arbor, MI, USA); abciximab was from Eli Lilly and Company (Indianapolis, IN, USA), while Fluo-4-AM was from Thermo Fisher Scientific Corporation (Waltham, MA, USA). TLCK was purchased from Merck KGaA /Calbiochem (Darmstadt, Germany).
+ Open protocol
+ Expand
4

Antibody and Reagent Identification for Protein Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The phospho-(Ser) PKC substrate (pSer PKC substrate) antibody was from Cell Signaling Technology (Danvers, MA, USA). The cytohesin-2 western blot antibody, ARF6 antibody and GAPDH antibody were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The cytohesin-2 immunoprecipitation antibody was from Thermo Scientific (Loughborough, Leicestershire, UK). Horseradish peroxidase (HRP)-conjugated donkey anti-rabbit, anti-mouse and anti-goat secondary antibodies were from Jackson ImmunoResearch Laboratories (Newmarket, UK). The PKC inhibitor bisindolylmaleimide (BIM) IX (Ro 31-8220) and the inactive analogue BIM V were from Calbiochem (Nottingham, UK). The PKC inhibitors BIM I (GF 109203X), Go 6983 and ruboxistaurin (LY 333531) and the cytohesin-2 inhibitor SecinH3 were from Tocris (Bristol, UK). The GST-GGA3 construct was a generous gift from Professor Sidney Whiteheart (University of Kentucky, USA). Cross-linked collagen-related peptide (CRP) was synthesized by Professor Richard Farndale (University of Cambridge, UK). PE-P-selectin and FITC-PAC1 antibodies were from Emfret Analytics (Eibelstadt, Germany). Luciferin-luciferase was from Chronolog (Labmedics, Stockport, UK). NuPAGE LDS sample buffer was from Invitrogen (Carlsbad, CA, USA). ECL reagent was from GE Healthcare (Amersham, UK). All other reagents were from Sigma-Aldrich (Poole, UK).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!